CQS (US)’s Teladoc Health TDOC Stock Holding History

CQS (US)’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,681	Closed	-$798K	–	119
2021 Q4	$798K	Sell	8,681 -17,546	-67%	-$2.1M	0.05%	95
2021 Q3	$3.33M	Buy	26,227 +14,961	+133%	+$2.18M	0.19%	83
2021 Q2	$1.87M	Buy	+11,266	New	+$1.83M	0.1%	92

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CQS (US)'s TDOC Position: Q1 2022 in Review

CQS (US) sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 8,681 shares — an estimated $798K sold.

CQS (US) first reported a position in TDOC in Q2 2021 and held it in 3 quarters. The position peaked at $3.33M in Q3 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

CQS (US) reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
CQS (US) sold 8,681 Teladoc Health shares in Q1 2022, an estimated $798K.
CQS (US) first reported a position in Teladoc Health in Q2 2021 and held it in 3 quarters.
CQS (US)'s Teladoc Health position peaked at $3.33M in Q3 2021.
680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on CQS (US)'s 13F filing for Q1 2022, filed 12 May 2022.